The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.13
Bid: 0.12
Ask: 0.14
Change: 0.00 (0.00%)
Spread: 0.02 (16.667%)
Open: 0.13
High: 0.13
Low: 0.13
Prev. Close: 0.13
GUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Investment - Eagle Mountain Mining

22 Jul 2020 07:00

RNS Number : 6803T
Gunsynd PLC
22 July 2020
 

Gunsynd plc

 

("Gunsynd" or the "Company")

 

New Investment - Eagle Mountain Mining

 

Gunsynd Plc (AIM: GUN, AQSE: GUN) is pleased to announce that it has invested A$200,000 (approximately £110,000) in Eagle Mountain Mining Limited ("Eagle Mountain"), an ASX listed copper-gold exploration and development company (ASX: EM2). This investment provides Gunsynd with exposure to copper exploration which compliments the Company's recent investment in gold explorer Rincon Resources as announced on 22 and 23 June 2020.

 

The Eagle Mountain investment was executed on the following terms:

subscription for 1,538,462 ordinary shares at A$0.13 for a total consideration of A$200,000;the investment is a part of a of A$3.0 million capital raising supported by institutional investors; andthe intended use of funds will include a surface diamond drilling program of approximately 2,000 metres at the Eagle Mountain's high-grade Oracle Ridge Copper Mine Project ("Oracle Ridge") scheduled to commence Q3 2020, for the potential acquisition of prospective ground in the vicinity and to provide additional working capital for the company.

 

About Eagle Mountain Mining Limited

Eagle Mountain Mining Limited (ASX: EM2), established in 2017, is a copper-gold explorer focused on the strategic exploration and development of advanced and greenfield projects in Arizona.

Arizona is at the heart of America's mining industry and home to some of the world's largest copper discoveries, now owned by major mining companies including BHP, Rio Tinto, Freeport McMoRan and Hudbay. Eagle Mountain's Oracle Ridge and Silver Mountain Projects are within the Laramide Arc which hosts many of these significant copper porphyry deposits.

 

Oracle Ridge is a high grade, advanced stage underground copper/gold/silver project. The project includes an NI43-101 resource of 11.7mt at 1.57%Cu, 17.47g/t Ag and 0.18g/t Au. Eagle Mountain believes there is significant potential to expand the known resources through additional drilling, along with exploration at depth to define the source of the mineralisation.

 

Peter Ruse, a director of Gunsynd, has an interest in 467,422 shares, representing approximately 0.4% of Eagle Mountain's issued share capital prior to the current fundraising.

 

Peter Ruse, a director of Gunsynd, commented: "We are very pleased to announce this investment in Eagle Mountain, which will offer direct exposure to copper via the development and exploration of the Oracle Ridge project in Arizona, USA.

 

Copper prices hit a two-year high of $6,545 a tonne last week (13 July 2020), boosted by concerns over strikes and supply from Chile - the world's top copper producer. This marked a gain of more than 40% since touching four-year lows in March 2020 when economic activity slumped along with demand. Oracle Ridge contains high grade copper resources with significant gold and silver. Historical drill results of 7.7m @ 5.11% Cu, 9.1m@ 3.97% Cu and 18m @ 2.84% Cu show the potential of ore body.

 

We believe Eagle Mountain has a high-quality board and management team that have a proven track record of exploration and development success in the mining industry both in Australia and overseas. We understand this capital raising received support from the institutional investor market in Australia, displaying strong conviction to gain listed copper exposure."

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Forward Looking Statements

This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the Company's ability to execute and implement future plans, and the occurrence of unexpected events. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors.

The Directors of Gunsynd accept responsibility for this announcement.

 

 

For further information please contact:

 

Gunsynd plc

Hamish Harris/ Peter Ruse

 

 

+44 (0) 78 7958 4153

Cairn Financial Advisers LLP

James Caithie / Liam Murray

 

+44 (0) 20 7213 0880

 

Peterhouse Capital Limited

Lucy Williams

 

+44 (0) 20 7469 0936

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAKXFADNEEFA
Date   Source Headline
3rd Feb 20107:00 amRNSDirectorate Change
2nd Feb 20102:30 pmRNSResult of AGM
7th Jan 20107:00 amRNSPreliminary results
12th Nov 20097:00 amRNSBusiness Update
12th Nov 20097:00 amRNSClinical results from Phase II cosmetic study
28th Apr 20097:00 amRNSHalf Yearly Report
14th Apr 20097:00 amRNSRe Contract
3rd Nov 20087:00 amRNSFinal Results
25th Sep 20087:00 amRNSChange of Adviser
29th Aug 20087:00 amRNSTotal Voting Rights
12th Aug 200811:58 amRNSHolding(s) in Company
6th Aug 20081:13 pmRNSResult of EGM & Director's In
15th Jul 20087:00 amRNSProposed fundraising
3rd Jul 20087:00 amRNSProctor & Gamble Agreement
24th Apr 20087:00 amRNSInterim Results
25th Feb 20087:00 amRNSPositive Trial Results
4th Feb 200810:51 amRNSHolding(s) in Company
21st Dec 20072:50 pmRNSOral Healthcare Agreement
15th Nov 20074:03 pmRNSAnnual Report and Accounts
18th Oct 20077:01 amRNSPreliminary Results
16th Aug 20077:00 amRNSPhase I Results
13th Jun 20077:01 amRNSPhase I Acne Trial Starts
8th May 20077:02 amRNSCRO Appointment
30th Apr 20079:00 amRNSTotal Voting Rights
25th Apr 200710:45 amRNSDirector/PDMR Shareholding
24th Apr 20074:12 pmRNSAdditional Listing
20th Apr 20072:15 pmRNSDirector/PDMR Shareholding
19th Apr 20077:01 amRNSInterim Results
21st Mar 20075:43 pmRNSHolding(s) in Company
20th Mar 20075:26 pmRNSHolding(s) in Company
15th Mar 20075:01 pmRNSHolding(s) in Company
31st Jan 20077:01 amRNSPipeline Update
8th Jan 20075:57 pmRNSDirector/PDMR Shareholding
13th Dec 200610:08 amRNSTotal Voting Rights
13th Dec 20067:01 amRNSBoard Changes
21st Nov 20067:01 amRNSAnnual Report & Notice of AGM
28th Sep 20067:02 amRNSPreliminary Results
1st Aug 20067:01 amRNSProduct Development Update
26th Jun 20067:01 amRNSCOO & Board Appointment
3rd Apr 20064:23 pmRNSHolding(s) in Company
23rd Mar 20068:12 amRNSSyntopix Admission to AIM
23rd Mar 20068:11 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.